Previous Article | Next Article 
Journal of Clinical Microbiology, August 2000, p. 2829-2836, Vol. 38, No. 8
0095-1137/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Rapid Identification of Candida
dubliniensis Using a Species-Specific Molecular
Beacon
Steven
Park,1
May
Wong,2
Salvatore A. E.
Marras,1
Emily W.
Cross,1
Timothy E.
Kiehn,2
Vishnu
Chaturvedi,3
Sanjay
Tyagi,1 and
David S.
Perlin1,*
Public Health Research
Institute,1 and Memorial Sloan-Kettering
Cancer Center,2 New York, and
Wadsworth Center, New York State Health Department,
Albany,3 New York
Received 6 March 2000/Returned for modification 1 May 2000/Accepted 14 May 2000
 |
ABSTRACT |
Candida dubliniensis is an opportunistic fungal
pathogen that has been linked to oral candidiasis in AIDS patients,
although it has recently been isolated from other body sites. DNA
sequence analysis of the internal transcribed spacer 2 (ITS2) region of rRNA genes from reference Candida strains was used to
develop molecular beacon probes for rapid, high-fidelity identification of C. dubliniensis as well as C. albicans.
Molecular beacons are small nucleic acid hairpin probes that brightly
fluoresce when they are bound to their targets and have a significant
advantage over conventional nucleic acid probes because they exhibit a
higher degree of specificity with better signal-to-noise ratios. When applied to an unknown collection of 23 strains that largely contained C. albicans and a smaller amount of C. dubliniensis, the species-specific probes were 100% accurate in
identifying both species following PCR amplification of the ITS2
region. The results obtained with the molecular beacons were
independently verified by random amplified polymorphic DNA
analysis-based genotyping and by restriction enzyme analysis with
enzymes BsmAI and NspBII, which cleave
recognition sequences within the ITS2 regions of C. dubliniensis and C. albicans, respectively. Molecular
beacons are promising new probes for the rapid detection of
Candida species.
 |
INTRODUCTION |
Candida dubliniensis is a
newly recognized opportunistic pathogen that has been linked to oral
candidiasis in human immunodeficiency virus (HIV)-infected patients
(16, 25, 45, 47), although it has also been observed in
blood isolates from bone marrow transplant patients and oral and
vaginal isolates from non-HIV-infected patients (26, 29,
35). C. dubliniensis was initially difficult to distinguish from other Candida species in standard clinical
laboratory tests because of its closely shared phenotypic and genotypic
characteristics with C. albicans (45, 46).
However, more recently, phenotypic characteristics, including carbon
assimilation (7, 13, 33, 39), growth temperature
(34), immunofluorescence (3), and DNA-based
molecular approaches (7-9, 11, 15, 18, 48) have been used
to distinguish C. dubliniensis from other Candida species. C. dubliniensis is largely susceptible to existing
antifungal agents (30), although it can rapidly develop in
vitro fluconazole resistance (29). A small percentage of
isolates with fluconazole resistance have been reported (29,
30), with some isolates expressing common classes of multidrug
transporters (28). Ultimately, this propensity may present a
problem in the oral cavity, where other resistant Candida
species from HIV-infected patients are frequently encountered (1,
19, 29, 52). Given the growing recognition of C. dubliniensis as an opportunistic pathogen of immunosuppressed
patients, a rapid and reliable method for the identification of this
non-C. albicans species is an important clinical goal for
proper disease management.
The internal transcribed spacer 2 (ITS2) is a spacer region flanked by
the 5.8S and 28S rRNA genes and has been used to identify other
clinically important fungi such as Pneumocystis,
Aspergillus, and Cryptococcus spp. (11,
20-22, 36, 49). The ITS2 region can be amplified with universal
fungal primers ITS3 and ITS4 specific for conserved sequences in the
ends of the 5.8 and 28S rRNA genes (22). Use of the ITS2
region for species identification requires either direct sequence
analysis, which is highly accurate but time-consuming, or detection
with sequence-specific hybridization probes. However, the use of linear
probes for detection, whether amplified or not, can pose problems of
sensitivity and false-positive results, depending on the probe sequence
and hybridization conditions (14). Recently, molecular
beacons were introduced to overcome these limitations (51).
Molecular beacons are small, single-stranded nucleic acid hairpin
probes that brightly fluoresce when they are bound to their targets
(50, 51). They possess a loop-and-stem structure in which
the loop contains the complementary target sequence and the stem forms
by the annealing of short complementary nucleotide sequence arms
adjacent to the target sequence (Fig.
1A). A fluorophore is covalently linked
to the end of the stem sequence, and a quencher is covalently linked to
the other end. In free solution, molecular beacons do not fluoresce
because the stem structure keeps the fluorophore close to the quencher
and the fluorescence energy is absorbed and released as heat. However,
in the presence of target DNA, the loop sequence anneals to the target,
a probe-target hybrid is formed, forcing the stems that contain the
fluorophore and quencher to disassociate, and fluorescence occurs.
Molecular beacons have a significant advantage over conventional
nucleic acid probes because of their fidelity and ability for allele
discrimination (24, 50). This property has recently been
exploited for the detection of single-nucleotide base pair changes
within the rpoB gene of Mycobacterium
tuberculosis, which confers resistance to the antibiotic rifampin
(31, 32), and for the detection of allelic differences in
the human
-chemokine receptor 5 (CCR5) gene
(17). In addition, molecular beacons have been used to rapidly detect and quantitate four retroviruses responsible for AIDS
and T-cell lymphoma/leukemia (53).

View larger version (12K):
[in this window]
[in a new window]
|
FIG. 1.
(A) Molecular beacon consists of a stem-loop structure
with a fluorophore and a quencher bound to the ends of the probe. In
free solution, these probes are nonfluorescent because the stem hybrid
keeps the fluorophore close to the quencher. When the probe sequence in
the loop hybridizes to its target, forming a rigid double helix, a
conformational reorganization occurs that separates the quencher from
the fluorophore, restoring fluorescence. The figure is adapted from
Tyagi and Kramer (51). (B) Nucleotide sequence of the
Candida species-specific molecular beacons. The
22-nucleotide target sequence is complementary to the ITS2 region of
each Candida species. The fluorophore
tetrachloro-6-fluorescein (TET) was attached to the sulfhydryl group on
the 5' arm sequence and 4-(4'-dimethylaminophenylazo)benzoic acid
(DABCYL), a quencher, was attached to an amino group on the 3' arm
sequence to form the stem region of the molecular beacon.
|
|
In this report, we describe a method for the rapid identification of
C. dubliniensis in which a species-specific molecular beacon
probe that recognizes a 22-nucleotide target region in the ITS2 region
of this organism is used. The results of application of this probe were
compared with those of more conventional molecular biology-based
approaches that involve random amplified polymorphic DNA (RAPD)
analysis and restriction endonuclease analysis (REA).
 |
MATERIALS AND METHODS |
Strains and growth conditions.
Candida reference
strains C. albicans ATCC 90028 C. glabrata ATCC
90030, and C. krusei ATCC 6258, were obtained from American Type Culture Collection (Manassas, Va.). C. dubliniensis
reference strain NCPF3949 was obtained from the National Collection of
Yeast Cultures (Norwich, England). Clinical isolates of C. albicans and C. dubliniensis (isolates M1-23 and CST
23, respectively) were obtained from the Microbiology Laboratory at
Memorial Sloan-Kettering Cancer Center. The isolates were obtained from
21 patients over a period of 2 months (6 July 1998 to 13 September
1998) and were not epidemiologically related. Two strains, strains M1
(ATCC 18804) and M3, were laboratory test strains included in the panel
of test strains. The yeasts were presumably identified by tests for detection of the formation of germ tubes at 37°C in horse serum (Life
Technologies, Grand Island, N.Y.), production of chlamydospores on
cornmeal agar with polysorbate 80 (Becton Dickinson Microbiology Systems, Cockeysville, Md.), substrate assimilation with the API 20C
AUX and ID 32C systems (bioMérieux Inc., Hazelwood, Mo.), colorimetric growth on CHROMagar Candida plates (DRG
International, Mountainside, N.J.), and growth at 45°C. Growth at
45°C was assessed by removing a single colony and streaking it over
the surface of a Sabouraud dextrose agar plate (Becton Dickinson),
which was incubated at 45°C for 48 h. Colony formation on the
last three quadrants of the plate was considered good growth, while
growth on the first quadrant was considered poor growth (13,
30). All strains were maintained on Sabouraud dextrose agar (4%
[wt/vol] dextrose, 1% [wt/vol] peptone, 1.5% [wt/vol] agar [pH
5.6]) and were grown with shaking (~250 rpm) at 30°C in YPD medium
(1% [wt/vol] yeast extract, 2% [wt/vol] peptone, 2% [wt/vol]
dextrose [pH 5.7]).
RAPD analysis of genomic DNA.
Yeast cells were incubated at
37°C for 1 h in a suspension that contained 1 M sorbitol, 0.1 M
EDTA, 0.1% (wt/vol) Zymolyase-100T (Seikaguku Corp., Tokyo, Japan),
and 1% (vol/vol) 2-mercaptoethanol and that was adjusted to pH 7.5. Chromosomal DNA was purified with the Wizard genomic DNA purification
kit (Promega, Madison, Wis.). Standard PCR amplifications were
performed in a 50-µl reaction mixture that consisted of 33.5 µl of
nuclease-free water (Promega), 5 µl of 10× Buffer A (Promega), 3 µl of 25 mM MgCl2, 4 µl of 2.5 mM deoxynucleoside
triphosphates (PE Applied Biosystems, Foster City, Calif.), 2 µl of
primer 1 (25 µM; 5'-AACGCGCAAC-3'), 2 µl of primer 2 (25 µM; 5'-GAGGGTGGNGGNTCT-3') (IDTDNA, Coralville, Iowa), and 2 µl of
chromosomal DNA (approximately 100 ng). The reaction was initiated by
the addition of 0.5 µl of 5 U of Taq polymerase (Promega)
per µl. PCR was performed in a PTC-150 Minicycler (MJ Research,
Waltham, Mass.) with 45 cycles of a three-step program that consisted
of 94°C for 1 min (step 1), 37°C for 1 min (step 2), and 72°C for
3 min (step 3). The PCR products (4 µl) were separated on 20%
polyacrylamide gels in an X-Cell gel apparatus (Novex, Carlsbad,
Calif.) for ~3 h at 175 V.
Statistical analysis.
Similarity coefficients based on the
DNA fingerprinting patterns of prominent bands of
1,000 bp among all
isolates were calculated as the ratio of matches over the total number
of bands scored. Similarities were calculated as the arithmetic mean of
all pairwise distances between strain fingerprint patterns. Student's
t test was used to compare genetic similarities between
different groups of isolates. Banding patterns and similarity
coefficients were determined with the Molecular Analyst/Fingerprinting
Plus v.1.12 (Bio-Rad Laboratories, Hercules, Calif.) and the
statistical software GB-STAT 6.5 (Scolari, London, England).
P values of <0.05 were considered significant.
ITS2 amplification and REA.
PCR amplification of the ITS2
region was performed with fungus-specific universal primers ITS3
(5'-GCATCGATGAAGAACGCAGC-3') and ITS4
(5'-TCCTCCGCTTATTGATATGC-3') to amplify a conserved portion of the 5.8S ribosomal DNA (rDNA) region, the adjacent ITS2 region, and
a small portion of the 28S rDNA region, yielding products of 0.338 kb
for C. albicans and 0.343 for C. dubliniensis.
Full DNA sequence analysis of the PCR products obtained with universal fungal primers ITS3 and ITS4 specific for rDNA genes was used to
confirm the species identification, as described previously (11). The reaction mixture (total volume, 100 µl)
consisted of 2 µl of genomic DNA (~200 ng), 1 µl of 25 mM dNTP
(Promega), 1 µl of 5 U of Amplitaq Gold Taq polymerase (PE
Applied Biosystems) per µl, 10 µl of 10× buffer (100 mM Tris-HCl
[pH 8.3], 500 mM KCl, 15 mM MgCl2, 0.01% [wt/vol]
gelatin), 1 µl of universal fungal primers ITS3 and ITS4 (25 µM)
(IDTDNA) (14), and 84 µl of nuclease-free water (Promega).
The PCR mixture was subjected to PCR with the following cycling
conditions: 95°C for 10 min, followed by 40 cycles of 95°C for
30 s, 58°C for 1 min, and 72°C for 1 min and a final step of
72°C for 5 min. PCR-amplified products were purified with the
Qiaquick DNA Purification Kit (Qiagen, Valencia, Calif.). The PCR
amplification products (~500 ng) were digested with 1 µl of
restriction enzymes NspBII (C. albicans ITS2
specific) (AP Biotech, Piscataway, N.J.) and BsmAI (C. dubliniensis ITS2 specific) (New England Biolabs, Beverly, Mass.)
for 1 h and were analyzed by gel electrophoresis in a 1.5%
agarose gel.
Molecular beacon design and analysis.
Molecular beacons
specific for the ITS2 region of C. albicans and C. dubliniensis were designed on the basis of published probe
sequences (11) that were independently confirmed by DNA sequence analysis at the New York University DNA sequencing facility. Target sequence selection, beacon design, and synthesis were optimized by standard protocols available on the Public Health Research Institute's website for molecular beacons
(http://www.molecular-beacons.com), as described by Tyagi and colleagues
(50, 51). Each molecular beacon possessed a 6-nucleotide arm
sequence and a 22-nucleotide probe target recognition sequence, as
follows: 5'-GCTAAGGCGGTCTCTGGCGTCG (C. dubliniensis) and 5'-TAGGTCTAACCAAAACATTGC (C. albicans). The arm sequences 5'-GCGAGG and
3'-CCTCGC were designed to form a stable stem hybrid at the
annealing temperature of the PCR to ensure that nonhybridized probes
remained in a hairpin conformation (no fluorescence). The fluorophore
tetrachloro-6-carboxyfluorescein and the quencher
4-(4'-dimethylaminophenylazo)benzoic acid (Molecular Probes Inc.,
Eugene, Oreg.) were covalently attached to the 5' and 3' ends of the
arm sequences, respectively. Real-time PCR amplification was performed
with 2 µl of species-specific molecular beacons (100 ng) in a 50-µl
reaction volume that contained 2 µl of genomic DNA (200 ng), 0.5 µl
of 25 mM nucleotide mix (Promega), 0.5 µl of 5 U of Amplitaq Gold
Taq polymerase (PE Applied Biosystems) per µl, 5 µl of
10× buffer (100 mM Tris-HCl [pH 8.3], 500 mM KCl, 15 mM
MgCl2, 0.01% [wt/vol] gelatin), 5 µl of 25 mM
MgCl2, 1 µl of universal fungal primers ITS3 and ITS4 (1 mg/ml), and 33 µl of nuclease-free water (Promega). The PCR mixture
was subjected to PCR with the following cycling conditions: 95°C for
10 min, followed by 40 cycles of 95°C for 30 s, 58°C for 1 min, and 72°C for 1 min in a Prism 7700 96-well spectrofluorometric
thermal cycler (PE Applied Biosystems).
 |
RESULTS |
RAPD analysis.
A collection of 23 Candida isolates
that mostly contained C. albicans and a smaller number of
C. dubliniensis strains was assembled by the Microbiology
Laboratory at Memorial Sloan-Kettering Cancer Center from stock
cultures. The collection was provided for a blind evaluation of
C. dubliniensis. Initially, all 23 strains were subjected to
random primed RAPD genotyping analysis to assess the relative genomic
relatedness of the strains. The RAPD fragments for all 23 isolates
displayed a profile of more than 15 prominent bands, with sizes ranging
from 0.1 to 1 kb (Fig. 2), with nearly identical profiles produced in three separate trials. Two distinct banding profiles were identified in which band similarities of greater
than 0.8 (band similarity coefficient, 0 to 3 band differences) were
found when the band profiles for common strains in the set were
compared (P < 0.05), but similarities of less than 0.5 were found when the band profiles between strains of the two sets were compared (P < 0.05). The major group included strains
M1, M2, M4, M6 to M9, M12 to M14, M17, M18, and M20 to M23, whose
patterns matched that of a reference C. albicans strain,
while the minor group consisted of M3, M5, M10, M11, M15, M16, and M19,
whose patterns matched the pattern observed from a C. dubliniensis reference strain (not shown).

View larger version (73K):
[in this window]
[in a new window]
|
FIG. 2.
RAPD analysis of 23 Candida isolates. Genomic
DNA was extracted and purified from each isolate, and PCR amplification
was performed with random primers, as described in Materials and
Methods. The PCR-amplified products were run on a 20%
Tris-borate-EDTA-polyacrylamide gel and stained with GelStar (FMC
Bioproducts). *, suspected C. dubliniensis strain.
|
|
REA.
PCR amplification of the ITS2 region with universal
fungal primers ITS3 and ITS4 (22) was used to generate
~0.3-kb fragments from all 23 isolates. The fragments were analyzed
with restriction enzyme BsmAI, which has a specific sequence
recognition sequence in this region from C. dubliniensis.
Figure 3A shows that 7 of the 23 amplified products were cut by this restriction enzyme, yielding
fragments of 0.25 and 0.9 kb. These restricted amplicons were derived
from the same subset of seven strains identified by RAPD analysis (Fig.
2). The remaining PCR-amplified products could be cut with restriction
enzyme NspBII, which specifically recognizes a site in the
ITS2 region from C. albicans to yield fragments of ~0.18
and 0.16 kb (Fig. 3B).

View larger version (49K):
[in this window]
[in a new window]
|
FIG. 3.
The ITS2 region was PCR amplified with universal fungal
primers ITS3 and ITS4, and the products were digested with restriction
enzymes BsmAI (C. dubliniensis specific) (A) and
NspBII (C. albicans specific) (B). The
restriction fragments were run on a 1.2% agarose gel and stained with
GelStar (FMC Bioproducts). *, C. dubliniensis strains.
|
|
Specificity and sensitivity of molecular beacon assay.
Species-specific molecular beacons were designed to target sequences
within the ITS2 regions of C. albicans and C. dubliniensis (Fig. 1B). Real-time PCR was performed with each of
the molecular beacons with DNA from reference strains of C. albicans, C. dubliniensis, C. glabrata, and
C. krusei. Fluorescence was detected for each of the
molecular beacons only in the prescence of its proper DNA target (Fig.
4). There was no effect of excess
nontarget amplicons on the signal of the molecular beacon. The
sensitivity of the C. dubliniensis-specific molecular beacon
was evaluated by serially diluting genomic DNA 105-fold
from a starting amount of 100 ng. The molecular beacon was able to
detect the target when ~100 pg of the initial genomic DNA was present
(Fig. 5). This result further illustrates
that molecular beacons have the ability to quantify target DNA in a real-time PCR assay (6).

View larger version (24K):
[in this window]
[in a new window]
|
FIG. 4.
Selectivities of species-specific molecular beacons for
reference Candida strains. In this experiment,
species-specific molecular beacons, as indicated in the panels, were
used to probe individual DNAs from the four Candida species.
Real-time PCR amplification of the ITS2 regions of four reference
Candida strains was performed with 100 ng of beacons and
~200 ng of genomic DNA for 40 cycles in a Prism 7700 96-well
spectrofluorometric thermal cycler (PE Applied Biosystems).
|
|

View larger version (21K):
[in this window]
[in a new window]
|
FIG. 5.
Real-time PCR amplification for determination of
relative sensitivity was performed for 40 cycles with C. dubliniensis genomic DNA (~100 ng) that was serially diluted
105-fold, as indicated, in the presence of a fixed amount
(100 ng) of the molecular beacon. Relative fluorescence was monitored
in a PE Applied Biosystems 7700 Prism 96-well spectrofluorometric
thermal cycler.
|
|
Detection of C. dubliniensis.
The molecular beacon
specific for C. dubliniensis was used to probe all 23 Candida isolates, along with reference strains of C. albicans, C. dubliniensis, C. glabrata, and
C. krusei. Figure 6 shows that
cycle-dependent amplification of the signal from the C. dubliniensis-specific molecular beacon was obtained only for the
seven suspected C. dubliniensis strains, strains M3, M5, M10, M11, M15, M16, and M19. All 23 isolates were also probed with the
C. albicans-specific molecular beacon, and a fluorescence signal was obtained only for the 16 isolates which the C. dubliniensis probe did not detect (data not shown). Table
1 summarizes the results obtained by the
three different DNA-based species identification methods (analysis with
molecular beacons, RAPD analysis, and REA) and demonstrates that the
results obtained by analysis with molecular beacons showed a 100%
correlation with the results obtained by the other approaches.

View larger version (17K):
[in this window]
[in a new window]
|
FIG. 6.
Real-time detection of C. dubliniensis from a
blinded panel of 23 Candida isolates was accomplished by PCR
amplification of the ITS2 region in the presence of a molecular beacon
specific for C. dubliniensis. Relative fluorescence was
monitored in a PE Applied Biosystems 7700 Prism 96-well
spectrofluorometric thermal cycler. Control DNAs from reference strains
of C. albicans, C. krusei, and C. glabrata were also evaluated.
|
|
 |
DISCUSSION |
The increasing prevalence of fungal infections caused by
non-C. albicans species that display clinical resistance or
reduced susceptibility to common azole-based antifungal drugs has
created a need to rapidly differentiate between Candida
species early in infection to assist in proper therapeutic management.
Conventional morphology and carbon assimilation tests require several
days or more for identification (54) and may misidentify
some species. C. dubliniensis is an example of such a
misidentified organism that is now readily turning up in the stock
culture collections of C. albicans from numerous clinical
laboratories (45, 47). In the last few years, several new
methods have been developed to distinguish the phenotypic properties of
this organism from those of other Candida species, including
chlamydospore formation (44), carbon assimilation
(39), temperature-dependent growth (34), colony
coloration on CHROMagar (16), and immunofluorescence (3), as have commercially available systems (API20C AUX,
RapID Yeast Plus, VITEK YBC, and VITEK 2 ID-YST) (13, 33).
Despite advances in phenotypic detection, species identification by
these routes is relatively slow. Genotyping with hybridization probes such as the C. albicans mid-repeat-sequence probes 27A and
Ca3 (2, 8, 40) and the C. dubliniensis-specific
complex probe Cd25-1 (15) can be used to provide species and
subspecies information. These techniques, however, are typically too
labor intensive for a clinical laboratory setting and are more suited
for epidemiological investigations.
Nucleic acid amplification of species-specific target sequences by PCR
or ligase chain reaction, or with RNA-dependent Q
replicase provides
the most rapid alternative to standard testing (14) since
few fungal cells are required. This high level of sensitivity is
particularly attractive for the early detection of fungemias, which are
difficult to detect by conventional procedures like blood culture or
those that depend upon a competent immune system (27). The
detection of 1 to 2 CFU per ml of blood can generally be achieved,
provided the target gene is present in numerous (>100) copies
(10). While the sensitivity associated with PCR
amplification can be maximized to detect low levels of pathogenic
organisms, PCR assays applied in clinical diagnostics have drawbacks
due to potential contamination with environmental organisms,
coamplification of human DNA, false priming, and/or the necessity for
additional hybridization steps (43). Furthermore, PCR
products are rarely validated other than by size, and detection schemes
that involve linear probes may have limited fidelity and limited
overall sensitivity.
Recently, a promising method for rapid identification of
Candida spp., including C. dubliniensis, with
sequence-specific digoxigenin-labeled hybridization probes in a
PCR-enzyme immunoassay format was described (11, 12, 41,
42). This method is robust but requires a posthybridization step
to remove the contaminating unhybridized probe that can lead to
false-positive results. Typically, any time that linear probes are used
for detection, there is a risk that false annealing may occur.
Probe-target hybridization is highly temperature dependent, and
depending on the nucleotide composition of the probe, random annealing
can pose a problem, especially when one is dealing with sequences with
high G+C contents, since the temperature profile for annealing is
shifted downward (5, 38).
To overcome a number of the inherent problems associated with nucleic
acid amplification and detection, we have applied molecular beacon
technology to detect PCR-amplified target sequences in the ITS2 regions
of C. dubliniensis and C. albicans. Using this technology, we readily detected all seven C. dubliniensis
strains from a panel of 23 unknown Candida isolates (Fig.
6). The molecular beacon analysis data were independently validated by
less robust molecular approaches involving RAPD analysis-based
genotyping and REA of target recognition sequences in the ITS2 regions
of C. dubliniensis and C. albicans. The ITS2
region of fungi is a suitable target for species identification because
of its variability among species (11, 21, 22). In addition,
only a single primer set, ITS3 and ITS4, is required to amplify this
region from fungi because of the highly conserved domains of the 5.8S
and 28S rDNA genes that flank it. The targeting of high-copy-number RNA
genes is also an advantage because it increases the sensitivity of
detection of amplified DNA without the need for nested PCR techniques
(12). The total time required for sample preparation and
analysis of target sequences is typically less than 6 h starting
from pregrown colonies of ~1 mm.
Molecular beacons have a distinct advantage over linear fluorescent
probes because of their stem-and-loop structures (4, 6). In
this conformation, nonhybridized beacons remain dark because the
fluorophore is maintained close to the quencher. When bound to its
target, the beacon opens and fluoresces brightly. There is no
requirement for isolation of probe-target hybrids to measure
fluorescence, which eliminates any possible posthybridization contamination. Thus, molecular beacons can be added prior to
amplification and real-time fluorescence can be measured in a
single-step assay. Real-time monitoring of the PCR amplification allows
a quantitative measure of the starting template based on the
fluorescence signal as a function of PCR cycle (23), a
feature unavailable to endpoint assays such as PCR-enzyme immunoassay.
The use of hairpin-shaped molecular beacons in PCR assays provides
several advantages over the use of linear probes because the stem-loop
structure imparts an increased ability to discriminate single-base-pair
mismatches compared to that from the use of linear probes such as
TaqMan (4, 50). The hairpin shape makes mismatched probe-target hybrids less thermally stable than hybrids between corresponding linear probes. Thus, molecular beacons are more useful
for allele discrimination, which adds to their fidelity in monitoring
of authentic products in PCR amplifications. To successfully monitor a
PCR assay, the molecular beacon should be designed to hybridize to its
target at the PCR annealing temperature, whereas the free molecular
beacon should stay closed and nonfluorescent at higher temperatures. A
probe sequence should be chosen such that the molecular beacon
dissociates from its target at a temperature 7 to 10°C higher than
the annealing temperature of the PCR amplification (6) (see
the Public Health Research Institute website for molecular beacons
support). Finally, unlike linear hydrolysis probes, the quenching of
molecular beacons has been shown to occur through a collisional
mechanism that involves a direct transfer of energy from the
fluorophore to the quencher (4). This property enables a
common quencher molecule to be used with beacons, which increases the
number of possible fluorophores that can be used as reporters. This is
especially important for multiplexing of molecular beacons in a PCR
assay, which have been reported for the detection of viruses
(53) and drug resistance-conferring mutations in M. tuberculosis (31, 37).
In summary, our results indicate that species-specific molecular
beacons are a highly reliable tool for molecular biology-based identification of C. dubliniensis that overcomes many of the
inherent problems associated with nucleic acid amplification and
detection. The results in this study extend previous applications of
molecular beacons and demonstrate that they provide a rapid and highly
reliable method for detection of sequence-specific amplified DNA.
Molecular beacons are ideal tools for clinical diagnostics because of
their stability, high signal-noise property, real-time monitoring
capability, and high-throughput potential. We are developing a panel of
molecular beacons for molecular identification of numerous fungi.
Furthermore, since molecular beacons can be used with several different
fluorophores, they are amenable for use for detection of multiplex
sequences in a single reaction tube (53).
 |
ACKNOWLEDGMENTS |
This work was supported by a sole-source contract from the New
State Department of Health, Albany, N.Y. (to D.S.P.).
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Public Health
Research Institute, 455 First Ave., New York, NY 10016. Phone: (212) 578-0820. Fax: (212) 578-0804. E-mail:
perlin{at}phri.nyu.edu.
 |
REFERENCES |
| 1.
|
Alexander, B. D., and J. R. Perfect.
1997.
Antifungal resistance trends towards the year 2000. Implications for therapy and new approaches.
Drugs
54:657-678[Medline].
|
| 2.
|
Anderson, J.,
T. Srikantha,
B. Morrow,
S. H. Miyasaki,
T. C. White,
N. Agabian,
J. Schmid, and D. R. Soll.
1993.
Characterization and partial nucleotide sequence of the DNA fingerprinting probe Ca3 of Candida albicans.
J. Clin. Microbiol.
31:1472-1480[Abstract/Free Full Text].
|
| 3.
|
Bikandi, J.,
R. S. Millan,
M. D. Moragues,
G. Cebas,
M. Clarke,
D. C. Coleman,
D. J. Sullivan,
G. Quindos, and J. Ponton.
1998.
Rapid identification of Candida dubliniensis by indirect immunofluorescence based on differential localization of antigens on C. dubliniensis blastospores and Candida albicans germ tubes.
J. Clin. Microbiol.
36:2428-2433[Abstract/Free Full Text].
|
| 4.
|
Bonnet, G.,
S. Tyagi,
A. Libchaber, and F. R. Kramer.
1999.
Thermodynamic basis of the enhanced specificity of structured DNA probes.
Proc. Natl. Acad. Sci. USA
96:6171-6176[Abstract/Free Full Text].
|
| 5.
|
Borisova, O. F.,
A. K. Shchyolkina,
B. K. Chernov, and N. A. Tchurikov.
1993.
Relative stability of AT and GC pairs in parallel DNA duplex formed by a natural sequence.
FEBS Lett.
322:304-306[CrossRef][Medline].
|
| 6.
|
Cayouette, M.,
A. Sucharczuk,
J. Moores,
S. Tyagi, and F. R. Kramer.
1999.
Using molecular beacons to monitor PCR product formation.
Strategies Newsl.
12:85-88.
|
| 7.
|
Coleman, D.,
D. Sullivan,
B. Harrington,
K. Haynes,
M. Henman,
D. Shanley,
D. Bennett,
G. Moran,
C. McCreary, and L. O'Neill.
1997.
Molecular and phenotypic analysis of Candida dubliniensis: a recently identified species linked with oral candidosis in HIV-infected and AIDS patients.
Oral Dis.
3(Suppl. 1):S96-S101.
|
| 8.
|
Diaz-Guerra, T. M.,
E. Mellado,
M. Cuenca Estrella,
F. Laguna, and J. L. Rodriguez-Tudela.
1999.
Molecular characterization by PCR-fingerprinting of Candida dubliniensis strains isolated from two HIV-positive patients in Spain.
Diagn. Microbiol. Infect. Dis.
35:113-119[CrossRef][Medline].
|
| 9.
|
Donnelly, S. M.,
D. J. Sullivan,
D. B. Shanley, and D. C. Coleman.
1999.
Phylogenetic analysis and rapid identification of Candida dubliniensis based on analysis of ACT1 intron and exon sequences.
Microbiology
145:1871-1882[Abstract].
|
| 10.
|
Einsele, H.,
H. Hebart,
G. Roller,
J. Loffler,
I. Rothenhofer,
C. A. Muller,
R. A. Bowden,
J. van Burik,
D. Engelhard,
L. Kanz, and U. Schumacher.
1997.
Detection and identification of fungal pathogens in blood by using molecular probes.
J. Clin. Microbiol.
35:1353-1360[Abstract].
|
| 11.
|
Elie, C. M.,
T. J. Lott,
E. Reiss, and C. J. Morrison.
1998.
Rapid identification of Candida species with species-specific DNA probes.
J. Clin. Microbiol.
36:3260-3265[Abstract/Free Full Text].
|
| 12.
|
Fujita, S.,
B. A. Lasker,
T. J. Lott,
E. Reiss, and C. J. Morrison.
1995.
Microtitration plate enzyme immunoassay to detect PCR-amplified DNA from Candida species in blood.
J. Clin. Microbiol.
33:962-967[Abstract].
|
| 13.
|
Gales, A. C.,
M. A. Pfaller,
A. K. Houston,
S. Joly,
D. J. Sullivan,
D. C. Coleman, and D. R. Soll.
1999.
Identification of Candida dubliniensis based on temperature and utilization of xylose and -methyl-D-glucoside as determined with the API 20C AUX and Vitek YBC systems.
J. Clin. Microbiol.
37:3804-3808[Abstract/Free Full Text].
|
| 14.
|
Ieven, M., and H. Goossens.
1997.
Relevance of nucleic acid amplification techniques for diagnosis of respiratory tract infections in the clinical laboratory.
Clin. Microbiol. Rev.
10:242-256[Abstract].
|
| 15.
|
Joly, S.,
C. Pujol,
M. Rysz,
K. Vargas, and D. R. Soll.
1999.
Development and characterization of complex DNA fingerprinting probes for the infectious yeast Candida dubliniensis.
J. Clin. Microbiol.
37:1035-1044[Abstract/Free Full Text].
|
| 16.
|
Kirkpatrick, W. R.,
S. G. Revankar,
R. K. McAtee,
J. L. Lopez-Ribot,
A. W. Fothergill,
D. I. McCarthy,
S. E. Sanche,
R. A. Cantu,
M. G. Rinaldi, and T. F. Patterson.
1998.
Detection of Candida dubliniensis in oropharyngeal samples from human immunodeficiency virus-infected patients in North America by primary CHROMagar Candida screening and susceptibility testing of isolates.
J. Clin. Microbiol.
36:3007-3012[Abstract/Free Full Text].
|
| 17.
|
Kostrikis, L. G.,
S. Tyagi,
M. M. Mhlanga,
D. D. Ho, and F. R. Kramer.
1998.
Spectral genotyping of human alleles.
Science
279:1228-1229[Free Full Text].
|
| 18.
|
Kurzai, O.,
W. J. Heinz,
D. J. Sullivan,
D. C. Coleman,
M. Frosch, and F. A. Muhlschlegel.
1999.
Rapid PCR test for discriminating between Candida albicans and Candida dubliniensis isolates using primers derived from the pH-regulated PHR1 and PHR2 genes of C. albicans.
J. Clin. Microbiol.
37:1587-1590[Abstract/Free Full Text].
|
| 19.
|
Lopez-Ribot, J. L.,
R. K. McAtee,
L. N. Lee,
W. R. Kirkpatrick,
T. C. White,
D. Sanglard, and T. F. Patterson.
1998.
Distinct patterns of gene expression associated with development of fluconazole resistance in serial Candida albicans isolates from human immunodeficiency virus-infected patients with oropharyngeal candidiasis.
Antimicrob. Agents Chemother.
42:2932-2937[Abstract/Free Full Text].
|
| 20.
|
Lott, T. J.,
B. M. Burns,
R. Zancope-Oliveira,
C. M. Elie, and E. Reiss.
1998.
Sequence analysis of the internal transcribed spacer 2 (ITS2) from yeast species within the genus Candida.
Curr. Microbiol.
36:63-69[CrossRef][Medline].
|
| 21.
|
Lott, T. J.,
B. P. Holloway,
D. A. Logan,
R. Fundyga, and J. Arnold.
1999.
Towards understanding the evolution of the human commensal yeast Candida albicans.
Microbiology
145:1137-1143[Abstract].
|
| 22.
|
Lott, T. J.,
R. J. Kuykendall, and E. Reiss.
1993.
Nucleotide sequence analysis of the 5.8S rDNA and adjacent ITS2 region of Candida albicans and related species.
Yeast
9:1199-1206[CrossRef][Medline].
|
| 23.
|
Manganelli, R.,
E. Dubnau,
S. Tyagi,
F. R. Kramer, and I. Smith.
1999.
Differential expression of 10 sigma factor genes in Mycobacterium tuberculosis.
Mol. Microbiol.
31:715-724[CrossRef][Medline].
|
| 24.
|
Marras, S. A.,
F. R. Kramer, and S. Tyagi.
1999.
Multiplex detection of single-nucleotide variations using molecular beacons.
Genet. Anal.
14:151-156[Medline].
|
| 25.
|
Meiller, T. F.,
M. A. Jabra-Rizk,
A. Baqui,
J. I. Kelley,
V. I. Meeks,
W. G. Merz, and W. A. Falkler.
1999.
Oral Candida dubliniensis as a clinically important species in HIV-seropositive patients in the United States.
Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod.
88:573-580[CrossRef][Medline].
|
| 26.
|
Meis, J. F.,
M. Ruhnke,
B. E. De Pauw,
F. C. Odds,
W. Siegert, and P. E. Verweij.
1999.
Candida dubliniensis candidemia in patients with chemotherapy-induced neutropenia and bone marrow transplantation.
Emerg. Infect. Dis.
5:150-153[Medline].
|
| 27.
|
Morace, G.,
L. Pagano,
M. Sanguinetti,
B. Posteraro,
L. Mele,
F. Equitani,
G. D'Amore,
G. Leone, and G. Fadda.
1999.
PCR-restriction enzyme analysis for detection of Candida DNA in blood from febrile patients with hematological malignancies.
J. Clin. Microbiol.
37:1871-1875[Abstract/Free Full Text].
|
| 28.
|
Moran, G. P.,
D. Sanglard,
S. M. Donnelly,
D. B. Shanley,
D. J. Sullivan, and D. C. Coleman.
1998.
Identification and expression of multidrug transporters responsible for fluconazole resistance in Candida dubliniensis.
Antimicrob. Agents Chemother.
42:1819-1830[Abstract/Free Full Text].
|
| 29.
|
Moran, G. P.,
D. J. Sullivan,
M. C. Henman,
C. E. McCreary,
B. J. Harrington,
D. B. Shanley, and D. C. Coleman.
1997.
Antifungal drug susceptibilities of oral Candida dubliniensis isolates from human immunodeficiency virus (HIV)-infected and non-HIV-infected subjects and generation of stable fluconazole-resistant derivatives in vitro.
Antimicrob. Agents Chemother.
41:617-623[Abstract].
|
| 30.
|
Pfaller, M. A.,
S. A. Messer,
S. Gee,
S. Joly,
C. Pujol,
D. J. Sullivan,
D. C. Coleman, and D. R. Soll.
1999.
In vitro susceptibilities of Candida dubliniensis isolates tested against the new triazole and echinocandin antifungal agents.
J. Clin. Microbiol.
37:870-872[Abstract/Free Full Text].
|
| 31.
|
Piatek, A. S.,
A. Telenti,
M. R. Murray,
H. El-Hajj,
W. R. Jacobs, Jr.,
F. R. Kramer, and D. Alland.
2000.
Genotypic analysis of Mycobacterium tuberculosis in two distinct populations using molecular beacons: implications for rapid susceptibility testing.
Antimicrob. Agents Chemother.
44:103-110[Abstract/Free Full Text].
|
| 32.
|
Piatek, A. S.,
S. Tyagi,
A. C. Pol,
A. Telenti,
L. P. Miller,
F. R. Kramer, and D. Alland.
1998.
Molecular beacon sequence analysis for detecting drug resistance in Mycobacterium tuberculosis.
Nat. Biotechnol.
16:359-363[CrossRef][Medline].
|
| 33.
|
Pincus, D. H.,
D. C. Coleman,
W. R. Pruitt,
A. A. Padhye,
I. F. Salkin,
M. Geimer,
A. Bassel,
D. J. Sullivan,
M. Clarke, and V. Hearn.
1999.
Rapid identification of Candida dubliniensis with commercial yeast identification systems.
J. Clin. Microbiol.
37:3533-3539[Abstract/Free Full Text].
|
| 34.
|
Pinjon, E.,
D. Sullivan,
I. Salkin,
D. Shanley, and D. Coleman.
1998.
Simple, inexpensive, reliable method for differentiation of Candida dubliniensis from Candida albicans.
J. Clin. Microbiol.
36:2093-2095[Abstract/Free Full Text].
|
| 35.
|
Polacheck, I.,
J. Strahilevitz,
D. Sullivan,
S. Donnelly,
I. F. Salkin, and D. C. Coleman.
2000.
Recovery of Candida dubliniensis from non-human immunodeficiency virus-infected patients in Israel.
J. Clin. Microbiol.
38:170-174[Abstract/Free Full Text].
|
| 36.
|
Reiss, E.,
K. Tanaka,
G. Bruker,
V. Chazalet,
D. Coleman,
J. P. Debeaupuis,
R. Hanazawa,
J. P. Latge,
J. Lortholary,
K. Makimura,
C. J. Morrison,
S. Y. Murayama,
S. Naoe,
S. Paris,
J. Sarfati,
K. Shibuya,
D. Sullivan,
K. Uchida, and H. Yamaguchi.
1998.
Molecular diagnosis and epidemiology of fungal infections.
Med. Mycol.
36(Suppl. 1):249-257.
|
| 37.
|
Rhee, J. T.,
A. S. Piatek,
P. M. Small,
L. M. Harris,
S. V. Chaparro,
F. R. Kramer, and D. Alland.
1999.
Molecular epidemiologic evaluation of transmissibility and virulence of Mycobacterium tuberculosis.
J. Clin. Microbiol.
37:1764-1770[Abstract/Free Full Text].
|
| 38.
|
Rychlik, W.
1995.
Priming efficiency in PCR.
BioTechniques
18:84-86[Medline], 88-90.
|
| 39.
|
Salkin, I. F.,
W. R. Pruitt,
A. A. Padhye,
D. Sullivan,
D. Coleman, and D. H. Pincus.
1998.
Distinctive carbohydrate assimilation profiles used to identify the first clinical isolates of Candida dubliniensis recovered in the United States.
J. Clin. Microbiol.
36:1467[Free Full Text].
|
| 40.
|
Schmid, J.,
E. Voss, and D. R. Soll.
1990.
Computer-assisted methods for assessing strain relatedness in Candida albicans by fingerprinting with the moderately repetitive sequence Ca3.
J. Clin. Microbiol.
28:1236-1243[Abstract/Free Full Text].
|
| 41.
|
Shin, J. H.,
F. S. Nolte,
B. P. Holloway, and C. J. Morrison.
1999.
Rapid identification of up to three Candida species in a single reaction tube by a 5' exonuclease assay using fluorescent DNA probes.
J. Clin. Microbiol.
37:165-170[Abstract/Free Full Text].
|
| 42.
|
Shin, J. H.,
F. S. Nolte, and C. J. Morrison.
1997.
Rapid identification of Candida species in blood cultures by a clinically useful PCR method.
J. Clin. Microbiol.
35:1454-1459[Abstract].
|
| 43.
|
Skladny, H.,
D. Buchheidt,
C. Baust,
F. Krieg-Schneider,
W. Seifarth,
C. Leib-Mosch, and R. Hehlmann.
1999.
Specific detection of Aspergillus species in blood and bronchoalveolar lavage samples of immunocompromised patients by two-step PCR.
J. Clin. Microbiol.
37:3865-3871[Abstract/Free Full Text].
|
| 44.
|
Staib, P., and J. Morschhauser.
1999.
Chlamydospore formation on Staib agar as a species-specific characteristic of Candida dubliniensis.
Mycoses
42:521-524[CrossRef][Medline].
|
| 45.
|
Sullivan, D., and D. Coleman.
1997.
Candida dubliniensis: an emerging opportunistic pathogen.
Curr. Top. Med. Mycol.
8:15-25[Medline].
|
| 46.
|
Sullivan, D., and D. Coleman.
1998.
Candida dubliniensis: characteristics and identification.
J. Clin. Microbiol.
36:329-334[Free Full Text].
|
| 47.
|
Sullivan, D.,
K. Haynes,
J. Bille,
P. Boerlin,
L. Rodero,
S. Lloyd,
M. Henman, and D. Coleman.
1997.
Widespread geographic distribution of oral Candida dubliniensis strains in human immunodeficiency virus-infected individuals.
J. Clin. Microbiol.
35:960-964[Abstract].
|
| 48.
|
Sullivan, D. J.,
M. C. Henman,
G. P. Moran,
L. C. O'Neill,
D. E. Bennett,
D. B. Shanley, and D. C. Coleman.
1996.
Molecular genetic approaches to identification, epidemiology and taxonomy of non-albicans Candida species.
J. Med. Microbiol.
44:399-408[Abstract].
|
| 49.
|
Turenne, C. Y.,
S. E. Sanche,
D. J. Hoban,
J. A. Karlowsky, and A. M. Kabani.
1999.
Rapid identification of fungi by using the ITS2 genetic region and an automated fluorescent capillary electrophoresis system.
J. Clin. Microbiol.
37:1846-1851[Abstract/Free Full Text].
|
| 50.
|
Tyagi, S.,
D. P. Bratu, and F. R. Kramer.
1998.
Multicolor molecular beacons for allele discrimination.
Nat. Biotechnol.
16:49-53[CrossRef][Medline].
|
| 51.
|
Tyagi, S., and F. R. Kramer.
1996.
Molecular beacons: probes that fluoresce upon hybridization.
Nat. Biotechnol.
14:303-308[CrossRef][Medline].
|
| 52.
|
Vanden Bossche, H.,
F. Dromer,
I. Improvisi,
M. Lozano-Chiu,
J. H. Rex, and D. Sanglard.
1998.
Antifungal drug resistance in pathogenic fungi.
Med. Mycol.
36(Suppl. 1):119-128.
|
| 53.
|
Vet, J. A.,
A. R. Majithia,
S. A. Marras,
S. Tyagi,
S. Dube,
B. J. Poiesz, and F. R. Kramer.
1999.
Multiplex detection of four pathogenic retroviruses using molecular beacons.
Proc. Natl. Acad. Sci. USA
96:6394-6399[Abstract/Free Full Text].
|
| 54.
|
Warren, N. G., and K. G. Hazen.
1995.
Candida, Cryptococcus, and other yeasts of medical importance, p. 723-737.
In
P. R. Murray, E. J. Baron, M. A. Pfaller, F. C. Tenover, and R. H. Yolken (ed.), Manual of clinical microbiology, 6th ed. American Society for Microbiology, Washington, D.C.
|
Journal of Clinical Microbiology, August 2000, p. 2829-2836, Vol. 38, No. 8
0095-1137/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Metwally, L., Hogg, G., Coyle, P. V., Hay, R. J., Hedderwick, S., McCloskey, B., O'Neill, H. J., Ong, G. M., Thompson, G., Webb, C. H., McMullan, R.
(2007). Rapid differentiation between fluconazole-sensitive and -resistant species of Candida directly from positive blood-culture bottles by real-time PCR. J Med Microbiol
56: 964-970
[Abstract]
[Full Text]
-
Espy, M. J., Uhl, J. R., Sloan, L. M., Buckwalter, S. P., Jones, M. F., Vetter, E. A., Yao, J. D. C., Wengenack, N. L., Rosenblatt, J. E., Cockerill, F. R. III, Smith, T. F.
(2006). Real-Time PCR in Clinical Microbiology: Applications for Routine Laboratory Testing. Clin. Microbiol. Rev.
19: 165-256
[Abstract]
[Full Text]
-
Diaz, M. R., Fell, J. W.
(2005). Use of a Suspension Array for Rapid Identification of the Varieties and Genotypes of the Cryptococcus neoformans Species Complex. J. Clin. Microbiol.
43: 3662-3672
[Abstract]
[Full Text]
-
Balashov, S. V., Gardiner, R., Park, S., Perlin, D. S.
(2005). Rapid, High-Throughput, Multiplex, Real-Time PCR for Identification of Mutations in the cyp51A Gene of Aspergillus fumigatus That Confer Resistance to Itraconazole. J. Clin. Microbiol.
43: 214-222
[Abstract]
[Full Text]
-
Pancholi, P., Park, S., Perlin, D., Kubin, C., Della-Latta, P.
(2004). Molecular Characterization of Fluconazole Resistance in a Case of Candida albicans Ocular Infection. J. Clin. Microbiol.
42: 5938-5939
[Abstract]
[Full Text]
-
Borst, A., Theelen, B., Reinders, E., Boekhout, T., Fluit, A. C., Savelkoul, P. H. M.
(2003). Use of Amplified Fragment Length Polymorphism Analysis To Identify Medically Important Candida spp., Including C. dubliniensis. J. Clin. Microbiol.
41: 1357-1362
[Abstract]
[Full Text]
-
Bautista-Munoz, C., Boldo, X. M., Villa-Tanaca, L., Hernandez-Rodriguez, C.
(2003). Identification of Candida spp. by Randomly Amplified Polymorphic DNA Analysis and Differentiation between Candida albicans and Candida dubliniensis by Direct PCR Methods. J. Clin. Microbiol.
41: 414-420
[Abstract]
[Full Text]
-
Sancak, B., Rex, J. H., Paetznick, V., Chen, E., Rodriguez, J.
(2003). Evaluation of a Method for Identification of Candida dubliniensis Bloodstream Isolates. J. Clin. Microbiol.
41: 489-491
[Abstract]
[Full Text]
-
Selvarangan, R., Limaye, A. P., Cookson, B. T.
(2002). Rapid Identification and Differentiation of Candida albicans and Candida dubliniensis by Capillary-Based Amplification and Fluorescent Probe Hybridization. J. Clin. Microbiol.
40: 4308-4312
[Abstract]
[Full Text]
-
Gee, S. F., Joly, S., Soll, D. R., Meis, J. F. G. M., Verweij, P. E., Polacheck, I., Sullivan, D. J., Coleman, D. C.
(2002). Identification of Four Distinct Genotypes of Candida dubliniensis and Detection of Microevolution In Vitro and In Vivo. J. Clin. Microbiol.
40: 556-574
[Abstract]
[Full Text]
-
Fang, Y., Wu, W.-H., Pepper, J. L., Larsen, J. L., Marras, S. A. E., Nelson, Eric. A., Epperson, W. B., Christopher-Hennings, J.
(2002). Comparison of Real-Time, Quantitative PCR with Molecular Beacons to Nested PCR and Culture Methods for Detection of Mycobacterium avium subsp. paratuberculosis in Bovine Fecal Samples. J. Clin. Microbiol.
40: 287-291
[Abstract]
[Full Text]
-
Oliveira, K., Haase, G., Kurtzman, C., Hyldig-Nielsen, J. J., Stender, H.
(2001). Differentiation of Candida albicans and Candida dubliniensis by Fluorescent In Situ Hybridization with Peptide Nucleic Acid Probes. J. Clin. Microbiol.
39: 4138-4141
[Abstract]
[Full Text]
-
Chang, H. C., Leaw, S. N., Huang, A. H., Wu, T. L., Chang, T. C.
(2001). Rapid Identification of Yeasts in Positive Blood Cultures by a Multiplex PCR Method. J. Clin. Microbiol.
39: 3466-3471
[Abstract]
[Full Text]